<DOC>
	<DOCNO>NCT00693680</DOCNO>
	<brief_summary>Examination effect zinc supplementation imipramine therapy major depression .</brief_summary>
	<brief_title>Zinc Supplementation Imipramine Therapy</brief_title>
	<detailed_description>A placebo-controlled , double blind study zinc supplementation imipramine therapy conduct sixty , depress patient fulfil DSM-IV criterion major depression without psychotic symptom . After one week washout period , patient randomize two group treat imipramine receive daily either placebo ( n=30 ) zinc supplementation ( n=30 ) 12 week .</detailed_description>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<mesh_term>Imipramine</mesh_term>
	<mesh_term>Zinc</mesh_term>
	<criteria>patient fulfil DSMIV criterion moderate severe depressive episode one week washout period without pharmacotherapy psychotic symptom</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2008</verification_date>
	<keyword>depression</keyword>
	<keyword>antidepressant treatment</keyword>
	<keyword>zinc</keyword>
	<keyword>placebo</keyword>
</DOC>